Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination

PURPOSE: The coronavirus disease 2019 (COVID-19) pandemic has led to the approval of novel vaccines with different mechanisms of action. Until now, more than 4.7 billion persons have been vaccinated around the world, and adverse effects not observed in pre-authorization trials are being reported at...

Descripción completa

Detalles Bibliográficos
Autores principales: Hieber, Marie-Lisa, Sprute, Rosanne, Eichenauer, Dennis A., Hallek, Michael, Jachimowicz, Ron D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881936/
https://www.ncbi.nlm.nih.gov/pubmed/35218512
http://dx.doi.org/10.1007/s15010-022-01786-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881936/
https://www.ncbi.nlm.nih.gov/pubmed/35218512
http://dx.doi.org/10.1007/s15010-022-01786-y

Ejemplares similares